Ignite Creation Date:
2024-05-06 @ 6:54 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05823389
Status:
COMPLETED
Last Update Posted:
2023-04-21
First Post:
2023-04-07
Brief Title:
Flapless Emdogain in the Treatment of Periodontal Residual Pockets
Sponsor:
Arab American University Palestine
Organization:
Arab American University Palestine
Study Overview
Official Title:
The Use of Flapless Enamel Matrix Derivative in Treating Periodontal Residual Pockets A Single-centre Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
48 adult patients participated in a single-centre randomized clinical trial with split- mouth design They had presented at re-evaluation after initial non-surgical periodontal therapy steps 1 and 2 of periodontal therapy for generalized periodontitis with at least 2 teeth with residual probing pocket depths PPD 5 and 8 mm with bleeding on probing BOP Two teeth with similar PPD were randomized to receive re-instrumentation either with test or without control adjunctive flapless administration of EMD Differences in the changes of PPD and BOP from baseline to 6 and 12 months will be analysed and the frequencies of pocket closure PPD 4 mm and no BOP will be compared
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None